Topic viruses

Companies viruses

SIRION BIOTECH GmbH, Germany

SIRION BIOTECH is a technology leader in the field of functional gene analysis and cell models for basic research, drug and compound development. The company serves leading European and Japanese Drug and Biotech companies as a provider of latest technologies for them to advance identification of nov more

Products viruses

ELISA kits for the measurment of SDF-1/CXCL12

SDF-1α (CXCL12) is a CXC chemokine. The small basic protein (ca. 8 kDa) has no glycosylation site in its sequence. The homology properties of SDF-1α are unique among the chemokines more

News viruses

• H1N1 discovery paves way for universal flu vaccine: UBC research

  University of British Columbia researchers have found a potential way to develop universal flu vaccines and eliminate the need for seasonal flu vaccinations. Led by Prof. John Schrader, Canada Research Chair in Immunology and director of UBC's Biomedical Research Centre, the research team found that more

• How does the immune system fight off threats to the brain?

  Like a police officer calling for backup while also keeping a strong hold on a suspected criminal, immune cells in the brain take a two-tier approach to fighting off a threat, new research from the University of Michigan Health System finds.For the first time, the scientists managed to capture that more

• Oncgnostics GmbH obtains seed funding for financing preclinical and clinical trials

  Chemical alterations of the genetic information specifically occuring during carcinogenesis provide the basis for the innovative diagnostic tests that are developed by the newly established oncgnostics GmbH in Jena. These tests allow not only for an earlier, but also a more accurate detection of can more

White papers viruses

• Field-Flow Fractionation - The Universal Separation Principle for Particle and Macromolecule Characterization
  

  High molecular weight polymers, bio molecules or particles in a range of a few nanometers up to several microns are more and more important in science and technology. Many applications are based on the specific properties of these materials. For this reason, an exact knowledge of the molar mass or particle sizes distribution is essential for later application as well as for optimization of the production processes or quality control. In addition the knowledge about the chain structure of macromolecules or biopolymers as well as about the shape of particles is often necessary. For this reason those samples, which often can be very complex systems, have to be separated according to parameters such as e.g. hydrodynamic volume or molecular weight. After the separation process the resulting narrow dispersed fractions are detected with different techniques. more

• The New MagNA Pure 96 DNA and Viral NA Kits: Maximal Speed Combined with High Recovery
  

  The MagNA Pure 96 System is a brand-new system recently introduced to the market: it is a fully automated, ultra-fast system for high-throughput isolation of high- quality nucleic acids from various sample types that can handle sample volumes of up to 1 ml. The main features of the new system were described in the preceding Biochemica issue (4/2009). This system uses optimized kits with prefilled, ready-to-use reagents in combination with the appropriate automated isolation protocols. The configuration of the kits is based on the well-established magnetic bead technology that has been used successfully on different MagNA Pure Systems for many years now. The MagNA Pure 96 Kits are composed of reagent trays with different prefilled, sealed containers for the buffers and special bottles containing the magnetic particles. All kits are available as small-volume (SV) and large-­volume (LV) variants, depending on the sample amount to be processed. This article describes the features and the performance of the two M more

• HelpCorner - Gene Silencing
  

  more

Publications viruses

• Microparticle delivery of Interleukin‐7 to boost T‐cell proliferation and survival

  Abstract In HIV infections, homoeostasis of T cells is dysregulated such that there is a depletion of CD4+ T cells and a progressive loss of naïve CD4+ and CD8+ T cells. Methodologies that can improve the function of some or all of these cells will likely enhance immune responsiveness in HIV infe more

• Case Report: Risk of virus infection after accidental blood inoculation from a multi‐infected AIDS patient

  Abstract Infections caused by blood‐borne viruses such as hepatitis B and C and the human immunodeficiency virus (HIV) are associated commonly with needlestick injuries, especially in a hospital setting. A prospective investigation was conducted on a medical doctor who suffered an accidental need more

• Prevalence and genotype distribution of human papillomavirus infection of the cervix in Spain: The CLEOPATRE study

  Abstract Human papillomavirus (HPV) infection is a necessary cause of cervical cancer. The aim of this study was to estimate the prevalence of cervical HPV infection and HPV type‐specific distribution among women attending cervical cancer screening in Spain during 2007 and 2008. Women aged 18–65 more

Market studies viruses

• HIV / AIDS – Pipeline Review, H1 2012

  Introduction Global Markets Direct’s, 'HIV / AIDS - Pipeline Review, H1 2012', provides an overview of the HIV / AIDS therapeutic pipeline. This report provides information on the therapeutic development for HIV / AIDS, complete with latest updates, and special features on late-stage and discontin more

• HIV-AIDS Testing Markets

  There are an estimated 33.3 million people living with HIV (the virus which causes AIDS) worldwide and approximately 2.6 million people are newly-infected each year. While the Asian and African regions account for more than 90% of the HIV-infected population (with the highest number in Sub-Saharan A more

• iBio, Inc. (NYSE ) - Financial and Strategic SWOT Analysis Review

  iBio, Inc. (iBio, formerly iBioPharma, Inc.) is a biotechnology company, engaged in the development of vaccines and therapeutic proteins based on its plant-based iBioLaunch platform technology, which is used in the manufacture of biopharmaceuticals. Its products include influenza vaccines, biodefenc more

Websites viruses